Quick Answer
IGC Pharma, Inc. reported Gross Profit of $619.0 thousand for fiscal year 2025.
IGC Pharma, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $619.0K | -15.6% |
| 2024 | $733.0K | +65.8% |
| 2023 | $442.0K | +127.8% |
| 2022 | $194.0K | +71.7% |
| 2021 | $113.0K | -1.7% |
| 2020 | $115.0K | -12.9% |
| 2019 | $132.0K | +61.0% |
| 2018 | $82.0K | -62.4% |
| 2017 | $218.2K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $99.0K | -50.0% | -35.7% |
| June 30, 2025 | $154.0K | -5.5% | +48.1% |
| December 31, 2024 | $104.0K | -21.8% | -47.5% |
| September 30, 2024 | $198.0K | +13.8% | +21.5% |
| June 30, 2024 | $163.0K | -36.1% | +22.6% |
| December 31, 2023 | $133.0K | +30.4% | -23.6% |
| September 30, 2023 | $174.0K | +28.9% | -31.8% |
| June 30, 2023 | $255.0K | +79.6% | +150.0% |
- IGC Pharma, Inc. showed a decrease of -15.6% in Gross Profit compared to the prior fiscal year.
- Over the 2017–2025 period, IGC Pharma, Inc.’s gross profit has grown by 183.6% (from $218.2 thousand to $619.0 thousand).
- The most recent figure is from IGC Pharma, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: